Unicycive Therapeutics, Inc. (UNCY) Misses Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts UNCY Hot Sheet
Join SI Premium – FREE
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) reported Q2 EPS of ($0.29), $0.09 worse than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Unicycive Therapeutics, Inc. (UNCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- RBC Capital Upgrades LTC Properties (LTC) to Outperform
- Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
